BeyondSpring (BYSI) vs TherapeuticsMD (TXMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
TherapeuticsMD (TXMD) has outperformed BeyondSpring (BYSI) over the past year, gaining 89.6% versus a loss of 66.0%. Over five years, TXMD leads with a -94.4% price change compared with -96.3% for BYSI. BeyondSpring is the larger company by market cap ($25.0 million vs $23.3 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BYSI | TXMD |
|---|---|---|
| Share price | $0.609 | $2.01 |
| Market cap | $25.04M | $23.26M |
| 1-day change | -5.51% | +0.50% |
| YTD return | -62.64% | +23.31% |
| 1-year return | -65.98% | +89.62% |
| 5-year return | -96.32% | -94.42% |
| Forward P/E | — | 5.74 |
| EPS (TTM) | $-0.18 | $-0.04 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.44 | $2.95 |
| 52-week low | $0.566 | $1.03 |
| Distance from 52-week high | -75.04% | -31.86% |
| Average volume | 855.31K | 23.94K |
| Shares outstanding | 41.12M | 11.57M |
| Employees | 44 | 1 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Drug Manufacturers - Specialty & Generic |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TXMD has outperformed BYSI by 155.6 percentage points over the past year.
About BeyondSpring
BYSI stock →BeyondSpring Inc., a clinical stage biopharmaceutical company, focuses on developing and selling clinical-stage biopharmaceutical therapies focused on oncology and immunology. The company operates through two segments: the Plinabulin pipeline and the TPD platform.
Healthcare · Biotechnology · 44 employees
About TherapeuticsMD
TXMD stock →TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally.
Healthcare · Drug Manufacturers - Specialty & Generic · 1 employees
BYSI vs TXMD FAQ
Which is bigger, BeyondSpring or TherapeuticsMD?
BeyondSpring (BYSI) is larger, with a market capitalization of $25.04M compared with $23.26M for TherapeuticsMD (TXMD).
Which stock has performed better over the past year, BYSI or TXMD?
TXMD returned +89.62% over the past 12 months, compared with -65.98% for BYSI (price return, excluding dividends). Past performance does not predict future results.
Are BeyondSpring and TherapeuticsMD in the same industry?
Both are in the Healthcare sector, but in different industries: Biotechnology for BeyondSpring and Drug Manufacturers - Specialty & Generic for TherapeuticsMD.